Written By: BrightFocus Editorial Staff
New BrightFocus-funded research by Kristie Stefanoska, PhD, explores how a protein called tau, critical to Alzheimer’s, turns from a normal to a diseased state. This discovery presents a new target to potentially prevent or treat Alzheimer’s disease.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
Flinders University of South Australia
A team of BrightFocus Alzheimer’s Disease Research-funded scientists is exploring how home-based brain stimulation could improve memory, mood, and daily life for people living with Alzheimer’s disease.
Read the top headlines in Alzheimer’s clinical trials and healthcare platforms.
Sinaptica Therapeutics unveils breakthrough Phase 2 results for an experimental non-invasive treatment for Alzheimer’s disease.
Get the latest in Alzheimer’s screening and treatments.
Every Donation is a Step Forward in the Fight Against Alzheimer’s
Your donation powers cutting-edge research and helps scientists explore new treatments. Help bring us closer to a cure and provide valuable information to the public.
Donate Today
